Connect With The Experts

Pharmaceuticals Corporations - Axial

Members (137 results)

Neurogeneration

Corporation

    This member has no reported closed transactions.

Neurogeneration is a clinical stage biotechnology company developing repair strategies for aging and degenerative disorders of the central nervous system. Our proprietary products, derived from neural progenitor cells are expanded and characterized for therapies in advanced neurodegenerative disorders like Parkinson’s disease. We believe our unique approach for restorative therapies, clinically safe following our proof of concept study, will be shown to be effective in a planned Phase II trial. Other pilot clinical trials are targeting underserved and under-penetrated markets with…

Bristol-Myers Squibb Company (NYSE:BMY)

Corporation

    This member has no reported closed transactions.

Bristol-Myers Squibb is a global BioPharma company firmly focused on its Mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.Around the world, our medicines help millions of people in their fight against such diseases as cancer, cardiovascular disease, diabetes, hepatitis B, HIV/AIDS, rheumatoid arthritis and psychiatric disorders.At Bristol-Myers Squibb, our BioPharma strategy uniquely combines the reach and resources of a major pharma company with the entrepreneurial spirit and agility of a successful biotech company. With this…

Lundon Software

Corporation

    This member has no reported closed transactions.

Lundon Software has pioneered automated data analysis of receptor-ligand binding for homologous and heterologous competition and saturation analyses. AccuFit (TM Beckman Instruments) and ReceptorFit (TM Lundon) interface with gamma and scintillation counters to give throughput from raw binding data to completed statistical analyses. Lundon intends to expand its software to more complex systems of simultaneous equations (blood clotting cascade, immune reactions, ...). Lundon is the leading edge in the analysis of binding data.

Hearing Health Science, Inc.

Corporation

    This member has no reported closed transactions.

Hearing Health Science is an independent neuroscience company on a mission to solve hearing loss, one of the largest health problems of our time. Hearing loss happens everywhere throughout tech-driven urban culture and industry. Hundreds of millions are going deaf. The economic and social costs are measured in trillions. HHS founder Dr. Josef (Joe) Miller and his medical research team started pioneering research 30 years ago. Eventually they discovered the root causes of hearing loss. Then they discovered a nutritional approach for prevention. Their micronutrient formula is called…

Ennaid Therapeutics

Corporation

    This member has no reported closed transactions.

Ennaid Therapeutics is a global biopharmaceutical company using its unique, patented platform technology to safely and rapidly develop and commercialize therapeutics for infectious diseases. The Company’s lead compound, ETX-101, is an inhibitory peptide that inhibits all four strains of dengue virus, a mosquito-borne tropical disease that causes Dengue Fever, Dengue Hemorrhagic Fever or Dengue Shock Syndrome. We are accelerating the development and commercialization of a novel therapeutic that inhibits all four strains of Dengue virus followed by West Nile virus.Based on the discovery of…

Richmond Chemical Corporation

Corporation

    This member has no reported closed transactions.

Richmond Chemical Corporation is a chemical and biosciences company, established in 2000 by a team of former Monsanto employees with over 17 years experience in bringing chiral chemistry and bioscience technologies to the pharma marketplace. The company, headquartered in Illinois, is engaged in the manufacturing, distribution and sourcing of pharmaceutical and chemical intermediates, while also practicing innovative applied research.

SBH Sciences

Corporation

    This member has no reported closed transactions.

SBH Sciences, Inc. was founded in 1997 with the sole purpose of producing mammalian-derived recombinant cytokines. Today, we have drastically expanded our services to offer cytokine-measuring bioassays, in vitro anti-cancer and anti-inflammation lead drug development, as well as the development of ELISA kits and Multiplex analyses.In the last year, we have continued our diversification and through partnerships with several companies, our product line now includes specific enzymes, specific kinase activity analysis and in vivo cancer models.SBH Sciences has been an innovator in the…

Solabia Group

Corporation

    This member has no reported closed transactions.

Solabia Group: Converging Bio-Expertise and Sustainable Innovation. Having invested in the Cosmetics, Pharmaceutical, Nutritional, Diagnostics and Biotechnology sectors, Solabia benefits from a coherent ensemble of converging know-how that allows us to reach our goal : satisfy your needs! Our 5 Sectors: - Cosmetics - Pharmaceutical - Nutritional - Diagnostics - Biotechnology

Marsala Biotech, Inc.

Corporation

    This member has no reported closed transactions.

Marsala Biotech Inc. is an Oncology company developing new treatments for cancer. The Company's lead technology E10A, is being evaluated in head and neck cancer patients. Currently there are only 2 FDA approved drugs which have significant drawbacks. Phase III clinical trials of E10A are planned for 2013 in China and North America. In addition to a huge commercial potential, E10A would help address this significant unmet medical need.Marsala's lead product E10A has established potential to treat Head and Neck Cancer, which has a market potential of 3.2 billion USD. E10A also has synergistic…

Amorphex Therapeutics

Corporation

    This member has no reported closed transactions.

Amorphex Therapeutics is a clinical stage company developing patented technology to address the problems associated with topical ophthalmic drug delivery, a $5+billion dollar market that includes the primary treatment of glaucoma. Topical ophthalmic pharmaceuticals are typically self-administered via eye drops but inaccurate dosing, poor compliance and excessive side effects undermine their therapeutic benefits and true sales potential. Amorphex is developing TODDD™, a soft, non-invasive device that is completely concealed under the eyelid that continuously delivers therapeutic levels of…

Curtana Pharmaceuticals

Corporation

    This member has no reported closed transactions.

Curtana is a private, preclinical-stage pharmaceutical company developing novel first-in-class, small molecule therapeutics targeting cancer stem cells in the central nervous system for the treatment of glioblastoma (GBM) and other cancers.

Anida Pharma Inc.

Corporation

    This member has no reported closed transactions.

Anida Pharma is a privately owned pre-revenue biopharmaceutical company developing first-in-class treatments for major neurological and pediatric diseases and conditions which currently lack effective treatments: the prevention of brain injury of the newborn, the slowing of disease progression in amyotrophic lateral sclerosis (ALS; Lou Gehrig disease), and the prevention of drug-induced hearing loss in children undergoing cancer chemotherapy. With excellent experimental proof-of-concept data protected by strong IP Anida now aims to move its programs into clinical development. Anida is led by…

Cadence Research & Consulting

Corporation

    This member has no reported closed transactions.

Cadence is a communications, research and consulting firm focused on supporting our clients through greater awareness, knowledge and understanding of their markets. We offer services in three critical areas: market research, consulting and medical communications. Our innovative approach to project work leverage our capabilities across all three practice areas to drive efficiencies and deeper insights for all our clients.

HemoGenyx LLC

Corporation

    This member has no reported closed transactions.

HemoGenyx LLC, a privately held biopharmaceutical company, is developing new methods of hematopoietic system regeneration. Our goal is to eliminate the need for allogeneic bone marrow transplantations from medical practice and drastically improve autologous ones. We propose a new approach that is based on the use of a novel type of hemogenic cells that are 100% patient-matched and have not undergone the malignant transformations that are responsible for most leukemias and lymphomas.

Merz Aesthetics

Corporation

    This member has no reported closed transactions.

A Legacy in Pharmaceuticals Meets Innovation in Medical AestheticsIntroducing Merz Aesthetics.BioForm Medical, Inc. and Merz Pharmaceuticals GmbH have joined forces to create a fresh new approach to medical aesthetics for you and your patients.Fresh Thinking to revolutionize the way we support you and your patientsIntelligent Products from our expanding product portfolioPremier Customer Partnerships that put you and your practice at the center of everything we doExplore how Fresh Thinking, Intelligent Products and Premier Customer Partnershipsfrom the second largest field force in the…

Kona Deep

Corporation

    This member has no reported closed transactions.

One Liner Description: Kona Deep® - The ONLY all natural electrolyte water on this planet! Bottled at the source in Hawaii.Business Summary: We manufacture and bottle "Kona Deep®", a deep seawaterdrinking brand. Deep seawater has become the No.1 food export of Hawaii, havingsurpassed Macadamia Nuts and Coffee (combined) in 2007. In 2011, over $140,000,000in deep sea bottled drinking water was exported from the State of Hawaii. In 2012, KonaDeep® became the #1 top-selling deep seawater brand in the USA. Our plan is tobecome #1 in the global market by leveraging our status as the #1 brand in…

Pyxant Labs

Corporation

    This member has no reported closed transactions.

Pyxant Labs Inc. is a Contract Research Organization (CRO) providing laboratory services support to pharmaceutical companies in their drug development processes. We help pharmaceutical companies develop drugs.

Natural Vitamins Laboratory

Corporation

    This member has no reported closed transactions.

Natural Vitamins Laboratories is an industry leading manufacturer of health and wellness care solutions. Our products include a comprehensive line of nutritional supplements, multi-vitamins, minerals, herbs Established in 1993, Natural Vitamins Laboratories is committed to provide you with the lifelong benefits of sound nutrition and wellness practices.

Cubist Pharmaceuticals Inc. (NasdaqGS:CBST)

Corporation

    This member has no reported closed transactions.

Cubist Pharmaceuticalsis a bio-pharmaceutical company focused on the research, commercial­ization and creation of pharmaceutical products that address unmet medical needs in the acute care environment.

Learn More About Joining Axial as a Member

Request Information

Axial

Complete the Form for Full Directory Access

Source M&A deals, connect with buyers & investors, or hire an M&A advisor via Axial's lower middle market M&A platform.

Your information is safe and will never be shared or sold.

Interested in finding out how investors are using Axial to source deals? Request Information

Interested in connecting with strategic buyers, family offices and PE firms? Request Information

Connect with strategic buyers, family offices and PE firms Request Information

Join the Axial network to streamline your deal origination and buyer discovery process Request Information

Send a message to company